BMS-303141 is a potent inhibitor of ATP citrate lyase (ACL) (IC₅₀ = 0.13 µM for human recombinant ACL). BMS-303141 inhibits lipid s ynthesis in HepG2 cells with an IC₅₀ of 8 μM, and lowers plasma triglycerides in a murine hyperlipdemia model

Numero articolo: BIOV2821-50
Unità di misura: 50 MG
https://grogg-prod.braintec.cloud/web/image/product.template/923611/image_1920?unique=615cf7b

738,00 CHF 738.0 CHF 738,00 CHF

738,00 CHF

Not Available For Sale

    Questa combinazione non esiste.

    Tempo di consegna attuale su richiesta

    Produttore: BIOVISION
    Numero del produttore: 2821-50
    Temperatura di stoccaggio: Freezer (-20)

    BMS-303141 is a potent inhibitor of ATP citrate lyase (ACL) (IC₅₀ = 0.13 µM for human recombinant ACL). BMS-303141 inhibits lipid s ynthesis in HepG2 cells with an IC₅₀ of 8 μM, and lowers plasma triglycerides in a murine hyperlipdemia model